Glaucoma affects over 3 million people in the United States, and this number is projected to be 4.3 million by 2030 as the USA population ages. Glaucoma cost $6.1 billion in 2014 to the USA healthcare system, and it is projected to be $12 billion in 2032
Continue Reading
We recently received $2.7M in funding from The National Institutes of Health! NIH is the largest public funder of biomedical research in the world.
Continue Reading
Watch our webinar recap to learn about our unique opportunity to capitalize on AI-driven health screening software. CEO Alauddin Bhuiyan, CMO Thomas Gerson, and CMO Kate Adams hosted the online event!
Continue Reading
Diabetic Retinopathy, also referred to as Diabetic Eye Disease (DED), is a medical condition in which damage occurs to the retina due to diabetes mellitus. This is one of the leading causesof blindness in developed countries. It is caused by the damage to the blood vessels in the retina, the light-sensitive tissue at the back of the eye. Figure 1 shows the images of healthy vision and diabetic retinopathy patent's vision.
Continue Reading
age related macular degeneration (AMD) (Figure 1) is a retinal disorder and one of the leading causes of blindness in those over the age of 50 years in the developed world1,2,3 . It affects the macula which is responsible for read, write, drive, etc. - a part of the retina responsible for sharp, central vision needed for seeing things up close, such as reading, recognizing faces, and walking safely.
Continue Reading